Aripiprazole and Desvenlafaxine · Minor SPL band

SPL labels Aripiprazole + Desvenlafaxine as minor; Aripiprazole 19 / Desvenlafaxine 13 in that band.

Mechanism on file: Desvenlafaxine does not change how the body processes aripiprazole through the liver.

FDA SPL severity: Minor

Aripiprazole

Full Aripiprazole label record

Atypical Antipsychotic

Desvenlafaxine

Full Desvenlafaxine label record

Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

Aripiprazole + Desvenlafaxine · SPL mechanism field

Desvenlafaxine does not change how the body processes aripiprazole through the liver.

Minor band excerpt · Aripiprazole with Desvenlafaxine

Examples desipramine, atomoxetine, dextromethorphan, metoprolol, nebivolol, perphenazine, tolterodine 7.2 Drugs Having No Clinically Important Interactions with PRISTIQ Based on pharmacokinetic studies, no dosage adjustment is required for drugs that are mainly metabolized by CYP3A4 (e.g., midazolam), or for drugs that are metabolized by both CYP2D6 and CYP3A4 (e.g., tamoxifen, aripiprazole), when administered concomitantly with PRISTIQ [see Clinical Pharmacology (12.3) ].

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.